Revista de Osteoporosis y Metabolismo Mineral

Scope & Guideline

Empowering Research in Osteoporosis and Beyond

Introduction

Welcome to the Revista de Osteoporosis y Metabolismo Mineral information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Revista de Osteoporosis y Metabolismo Mineral, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageMulti-Language
ISSN1889-836x
PublisherSOC ESPANOLA INVESTIGACION OSEA & METABOLISMO MINERAL
Support Open AccessYes
CountrySpain
TypeJournal
Convergefrom 2014 to 2024
AbbreviationREV OSTEOPOR METAB M / Rev. Osteoporos. Metab. Min.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPASEO CASTELLANA, 135, 7A PLANTA, MADRID 28046, SPAIN

Aims and Scopes

The 'Revista de Osteoporosis y Metabolismo Mineral' focuses on advancing the understanding of osteoporosis and related metabolic bone diseases through comprehensive research and clinical studies. The journal encourages interdisciplinary collaboration and aims to disseminate knowledge that aids in the prevention, diagnosis, and treatment of these conditions.
  1. Osteoporosis Mechanisms and Pathophysiology:
    Research exploring the biological mechanisms underlying osteoporosis, including cellular and molecular pathways, hormonal influences, and genetic predispositions.
  2. Clinical Management and Treatment Strategies:
    Publications that provide insights into the efficacy, safety, and long-term outcomes of various therapeutic approaches for osteoporosis, including pharmacological treatments and lifestyle interventions.
  3. Risk Assessment and Predictive Tools:
    Studies focusing on the development and validation of risk assessment tools, such as the FRAX tool, to better predict fracture risks in diverse populations.
  4. Impact of Comorbidities on Bone Health:
    Investigations into how various comorbid conditions, such as diabetes and autoimmune disorders, influence bone metabolism and osteoporosis progression.
  5. Innovative Research Methodologies:
    Utilization of advanced research methods, including genetic studies, imaging techniques, and clinical trials, to explore new dimensions in osteoporosis research.
Recent publications in the 'Revista de Osteoporosis y Metabolismo Mineral' indicate a dynamic evolution of research themes, highlighting emerging areas of interest and growing trends within the field of osteoporosis and metabolic bone diseases.
  1. Personalized Medicine and Genetic Factors:
    An increasing focus on polygenic risk scores and genetic predispositions to osteoporosis signifies a shift towards personalized medicine, where treatments can be tailored based on individual genetic profiles.
  2. Role of Hormones in Bone Health:
    Research investigating the impact of sex hormones and other endocrine factors on bone metabolism is gaining traction, reflecting a deeper understanding of the hormonal regulation of bone health.
  3. Innovative Therapeutics and Treatment Approaches:
    The emergence of new anabolic drugs and treatment strategies for osteoporosis, such as abaloparatide and romosozumab, showcases a trend towards exploring novel therapeutic options.
  4. Multidisciplinary Approaches in Osteoporosis Management:
    The integration of multidisciplinary strategies, including collaboration among various healthcare professionals to manage osteoporosis, is becoming increasingly prevalent in research.
  5. Impact of Lifestyle and Comorbidities on Osteoporosis:
    There is a growing recognition of how lifestyle factors, such as diet and exercise, along with comorbid conditions, influence bone health, which is reflected in recent studies.

Declining or Waning

While the journal has consistently focused on various aspects of osteoporosis and metabolic bone diseases, certain themes have seen a reduction in publication frequency or focus over the years. This decline may reflect shifting research interests or advancements in the field.
  1. Basic Science Studies:
    There appears to be a diminishing emphasis on purely basic science research without direct clinical applications, as the journal increasingly prioritizes studies that translate findings into clinical practice.
  2. Historical Perspectives on Osteoporosis:
    Papers providing retrospective analyses or historical accounts of osteoporosis management have become less frequent, indicating a shift towards contemporary and forward-looking research.
  3. Nutritional Studies Unrelated to Bone Health:
    Research focusing solely on general nutritional studies without a clear link to bone health or osteoporosis has decreased, as the journal aims to concentrate on more relevant and impactful findings.
  4. Single-Country Studies:
    There is a noticeable reduction in studies that focus exclusively on osteoporosis in a single country, suggesting a trend towards more comparative and international research that can provide broader insights.
  5. Pharmacological Studies on Older Treatments:
    Publications centered around older osteoporosis treatments have waned, as the field is moving towards exploring newer therapeutic options and innovative treatment strategies.

Similar Journals

JOURNAL OF CLINICAL DENSITOMETRY

Elevating Standards in Radiology and Clinical Practice
Publisher: ELSEVIER SCIENCE INCISSN: 1094-6950Frequency: 4 issues/year

JOURNAL OF CLINICAL DENSITOMETRY, published by ELSEVIER SCIENCE INC, stands as a pivotal platform for the dissemination of cutting-edge research in the fields of endocrinology, orthopedics, and radiology. With an ISSN of 1094-6950 and an E-ISSN of 1559-0747, this journal supports the academic community with vital insights and advancements in clinical densitometry since its inception in 1998. The journal is recognized within the medical community, boasting impressive rankings such as Q3 in Endocrinology, Diabetes, and Metabolism, and Q2 in both Orthopedics and Sports Medicine and Radiology, Nuclear Medicine, and Imaging for 2023. These accolades underscore its significance as a valuable resource for researchers, healthcare professionals, and students aiming to advance their knowledge and practice in these critical areas. While it is not an Open Access publication, the journal provides vital contributions to the literature, emphasizing the importance of evidence-based approaches in clinical settings.

Actualizaciones en Osteologia

Pioneering Discoveries in Endocrinology and Orthopedics
Publisher: ASOC ARGENTINA OSTEOLOGIA & METABOLISMO MINERALISSN: 1669-8975Frequency: 3 issues/year

Actualizaciones en Osteología is a peer-reviewed academic journal dedicated to the dissemination of pivotal research in the field of osteoporosis and mineral metabolism. Published by ASOCIACIÓN ARGENTINA DE OSTEOLOGÍA & METABOLISMO MINERAL, this journal serves as a vital resource for professionals, researchers, and students in medicine, particularly within the subdomains of endocrinology, orthopedics, and radiology. With its ISSN 1669-8975 and E-ISSN 1669-8983, the journal has been operational since 2009 and is located in Córdoba, Argentina. Its increasing relevance is underscored by its categorization in the Q4 quartile across multiple medical disciplines, indicating a committed effort to enhance knowledge in these areas. Although it operates without an open-access model, the journal provides critical insights and updates that are making a significant impact in the evolving landscape of osteology and related fields. By participating in the discussions presented, contributors and readers alike can stay abreast of the latest innovations and research findings in bone health.

Neurological Sciences and Neurophysiology

Bridging clinical practice with cutting-edge research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2636-865XFrequency: 4 issues/year

Neurological Sciences and Neurophysiology, published by Wolters Kluwer Medknow Publications, serves as a pivotal platform for dissemination and discussion of recent advancements and research in the fields of neurology and neurophysiology. Since its transition to an Open Access format in 2020, this journal aims to enhance accessibility to crucial developments in neurological sciences for researchers, professionals, and students alike. With an ISSN of 2636-865X, it seeks to bridge the gap between clinical practice and experimental science, promoting innovative approaches to neurological disorders. While currently ranked in the Q4 quartile in the Neurology category, the journal is committed to improving its standing through rigorous peer review and publication of high-quality research. The journal's scope encompasses a wide range of topics, ensuring that it appeals to a diverse audience, while its Scopus ranks indicate its emerging presence in the global scientific community. Located in Mumbai, India, the journal welcomes contributions that push the boundaries of our understanding of the nervous system, making it a vital resource for scholars in this dynamic field.

Translational Psychiatry

Fostering collaboration for a brighter future in mental health.
Publisher: SPRINGERNATUREISSN: 2158-3188Frequency: 1 issue/year

Translational Psychiatry, an esteemed journal published by SpringerNature, is at the forefront of research in the fields of biological psychiatry, neuroscience, and mental health. With an impressive Q1 category ranking in Biological Psychiatry, Cellular and Molecular Neuroscience, and Psychiatry and Mental Health, the journal fosters high-quality scholarly work that informs clinical practices and guides future research directions. Since its inception in 2011, Translational Psychiatry has embraced the Open Access model, ensuring that groundbreaking findings are easily accessible to all, promoting collaboration and innovation within the global scientific community. With a solid ranking in Scopus—particularly at #33 out of 567 in Psychiatry and Mental Health and #6 out of 51 in Biological Psychiatry—this journal plays a critical role in advancing our understanding of mental health disorders, bridging the gap between bench science and clinical application. As it continues evolving through its converged years from 2011 to 2024, Translational Psychiatry remains an essential resource for researchers, healthcare professionals, and students dedicated to improving mental health outcomes.

INTERNATIONAL JOURNAL OF OBESITY

Elevating Understanding of Obesity and Health Outcomes
Publisher: SPRINGERNATUREISSN: 0307-0565Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF OBESITY, published by SpringerNature, stands as a premier multidisciplinary platform for research in the fields of Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics, as well as Miscellaneous Medicine. With a remarkable impact, the journal is consistently positioned in the Q1 category across these critical areas, underscoring its significance in advancing the understanding of obesity and its related health outcomes. Established in 1977 and covering a broad spectrum of studies until 2024, it boasts a notable Scopus Rank reflecting its influential contributions to the scientific community, including a rank of 14 out of 140 in Nutrition and Dietetics. The INTERNATIONAL JOURNAL OF OBESITY is not just a repository of knowledge but a vital resource for researchers, clinicians, and students aiming to explore the complexities of obesity and develop evidence-based interventions. Despite not being an open-access journal, its rigorous peer-reviewed articles remain accessible to those within academic institutions, facilitating an essential dialogue among professionals dedicated to this critical global health issue.

Lancet Diabetes & Endocrinology

Exploring the frontiers of metabolic health.
Publisher: ELSEVIER SCIENCE INCISSN: 2213-8587Frequency: 12 issues/year

Lancet Diabetes & Endocrinology is a premier peer-reviewed journal, published by Elsevier Science Inc, dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Established in 2013, this journal has quickly ascended to a position of notable prestige, reflected in its prestigious Q1 rank across various categories, including Endocrinology, Internal Medicine, and Diabetes & Metabolism. With an impressive impact factor and Scopus rankings placing it in the 99th percentile of its field, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal aims to disseminate high-quality research covering clinical and experimental aspects of metabolic and endocrine disorders, making it an indispensable tool for those looking to stay at the forefront of these rapidly evolving fields. With its focus on innovative depth and cutting-edge studies, Lancet Diabetes & Endocrinology continually fosters an international dialogue critical for advancements in diabetes and endocrinology.

DIABETES OBESITY & METABOLISM

Delivering cutting-edge research for a healthier future.
Publisher: WILEYISSN: 1462-8902Frequency: 12 issues/year

DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.

Sleep and Breathing

Advancing Knowledge in Sleep Medicine and Breathing
Publisher: SPRINGER HEIDELBERGISSN: 1520-9512Frequency: 4 issues/year

Sleep and Breathing is a leading international journal published by SPRINGER HEIDELBERG, specializing in the fields of neurology and otorhinolaryngology. Since its inception in 1996, the journal has established itself as a pivotal resource for clinicians and researchers exploring the complex interactions between sleep and respiratory health. With an impressive Q2 ranking in Neurology (clinical) and a Q1 ranking in Otorhinolaryngology, it serves a diverse readership, offering a rich repository of original research, reviews, and clinical studies that address critical challenges in sleep medicine. The journal currently boasts a robust Scopus ranking, placing it among the top-tier publications in both specialties (Rank #16/123 in Otorhinolaryngology and Rank #140/400 in Clinical Neurology). While access options are limited, the high impact factor underscores its significance in shaping contemporary research dialogue. As such, Sleep and Breathing continues to be an essential platform for advancing knowledge and fostering collaboration within the nexus of sleep science and respiratory health.

Endocrinology Diabetes and Metabolism Case Reports

Advancing Knowledge in Endocrinology and Metabolism
Publisher: BIOSCIENTIFICA LTDISSN: Frequency: 1 issue/year

Endocrinology Diabetes and Metabolism Case Reports, published by BIOSCIENTIFICA LTD, stands as a pivotal forum for sharing significant advancements and clinical case studies in the fields of endocrinology, diabetes, and metabolism. With an Open Access model initiated in 2013, this journal encourages the widespread dissemination and accessibility of research findings, promoting collaboration and innovation among scholars and healthcare professionals. Based in the United Kingdom, the journal features a focus on practical applications and unique case reporting that enriches the clinical understanding and management of complex endocrine disorders. Though currently it's ranked in the Q3 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, its ongoing commitment to quality and impact in clinical research makes it a valuable resource for researchers, professionals, and students alike, contributing to the advancement of knowledge in this critical medical domain.

Austrian Journal of Clinical Endocrinology and Metabolism

Bridging research and practice in metabolic health.
Publisher: SPRINGER WIENISSN: 1998-7773Frequency: 4 issues/year

Austrian Journal of Clinical Endocrinology and Metabolism, published by SPRINGER WIEN, serves as a pivotal platform for the dissemination of research in the field of endocrinology, diabetes, and metabolism. With its ISSN 1998-7773 and E-ISSN 1998-7781, this journal has been contributing valuable insights to the field since its inception in 2010. Although it currently holds a Q4 ranking in the category of Endocrinology, Diabetes and Metabolism, it is committed to improving its impact factor by showcasing high-quality, peer-reviewed articles that reflect contemporary challenges and innovations in clinical endocrinology. Located in Vienna, Austria, the journal aims to provide researchers, healthcare professionals, and students with access to the latest findings and clinical practices that advance understanding and treatment of endocrine disorders. Researchers interested in submitting their work will find a supportive environment that embraces both experimental and clinical approaches. The Austrian Journal of Clinical Endocrinology and Metabolism is poised to become a valuable resource for those dedicated to improving health outcomes in metabolic disorders.